Fundraising FoxTPG — 2024 Investments
5 investments dated 2024 · listed companies and verified rows first · show all
Bicara Therapeutics is a clinical-stage biopharmaceutical company developing bifunctional antibody therapies that combine tumor-targeting with immune-modulating payloads to treat solid tumors.
Ivan Hyep(Chief Financial Officer and Treasurer)inLara Meisner(Chief Legal Officer, Compliance Officer and Corporate Secretary)inDavid Raben(Chief Medical Officer)in
Co-investorsAisling CapitalEight Roads VenturesF-Prime CapitalForesite CapitalPremji InvestRA Capital+6 more
G&A Partners provides customized HR solutions and integrated technology for managing payroll, benefits, and human capital management processes.
Enterprise SoftwareHR TechSaaSHouston, US
Antonio "Tony" Grijalva(Founder)John W. Allen(Founder)Jeff Williams(President and CEO)Aaron Call, PHRin
Co-investorsSaxeCap AdvisorsGeneral Atlantic
Sayari provides forensic investigation services using corporate records, trade data, and network analysis to uncover hidden risk networks across sanctions evasion, financial crime, counternarcotics, and adversary operations for law enforcement and government clients.
AI & Machine LearningEnterprise SoftwareFintechGovTechLegalTechWashington, US
Farley Mesko(Chief Executive Officer)inEric Rhoades(Executive Officer)inBenjamin Power(Executive Officer)inDavid Asher(Executive Officer)in
BoardMike Zappert(Director)Benjamin Cukier(Director)
Co-investorsIn-Q-TelCentana Growth PartnersCentana PartnersIronGate Capital AdvisorsJoule VenturesLavrock Ventures+3 more
Shadowfax operates a logistics and delivery network in India, using a crowdsourced fleet of trucks, delivery partners, and agents to provide same-day and next-day courier and delivery services.
AI & Machine LearningE-commerceLogistics & Supply Chain
Abhishek Bansal(Founder)inPraharsh Chandra(Founder)in
Co-investorsNewBuild.VCNGP CapitalQualcomm VenturesTitan CapitalTrifecta Capital AdvisorsEight Roads Ventures+2 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.